Effect of sucrose as a lyoprotectant on the integrity of paclitaxel-loaded liposomes during lyophilization

Journal of Liposome Research

Volumn 25, Issue 4, 2015, Pages 270-278

  Kannan, Vinayagam ^a   Balabathula, Pavan ^a   Thoma, Laura A ^a   Wood, George C ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Freeze drying; lyoprotection; nanotechnology

Indexed keywords

HYDROGEN; LIPID; LIPOSOME; MANNITOL; PACLITAXEL; SUCROSE; SUGAR; TREHALOSE; DRUG CARRIER;

ARTICLE; CRYSTALLIZATION; DISPERSION; ENCAPSULATION; FREEZE DRYING; HEATING; HYDROGEN BOND; HYDROLYSIS; MOISTURE; OXIDATION; PARTICLE SIZE; PRIORITY JOURNAL; STORAGE; TRANSITION TEMPERATURE; ZETA POTENTIAL; CHEMICAL PHENOMENA; CHEMISTRY; SURFACE PROPERTY;

DRUG CARRIERS; FREEZE DRYING; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LIPOSOMES; PACLITAXEL; PARTICLE SIZE; SUCROSE; SURFACE PROPERTIES;

EID: 84945944149     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982104.2014.992023     Document Type: Article

References (34)

1. Amidon GL, Lennernas H, Shah VP, Crison JR. (1995). A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 12:413-20.
2. Chen C, Han D, Cai C, Tang X. (2010a). An overview of liposome lyophilization and its future potential. J Control Release 142:299-311.
3. Chen C, Han D, Zhang Y, et al. (2010b). The freeze-thawed and freezedried stability of cytarabine-encapsulated multivesicular liposomes. Int J Pharm 387:147-53.
4. Crowe JH, Crowe LM. (1988). Factors affecting the stability of dry liposomes. Biochim Biophys Acta 939:327-34.
5. Crowe JH, Crowe LM, Chapman D. (1984). Preservation of membranes in anhydrobiotic organisms: the role of trehalose. Science 223:701-3.
6. Crowe JH, Crowe LM, Oliver AE, et al. (2001). The trehalose myth revisited: introduction to a symposium on stabilization of cells in the dry state. Cryobiology 43:89-105.
7. Crowe JH, Hoekstra FA, Nguyen KH, Crowe LM. (1996). Is vitrification involved in depression of the phase transition temperature in dry phospholipids? Biochim Biophys Acta 1280:187-96.
8. Crowe LM, Crowe JH, Rudolph A, et al. (1985). Preservation of freezedried liposomes by trehalose. Arch Biochem Biophys 242:240-7.
9. Green JL, Angell CA. (1989). Phase relations and vitrification in saccharide-water solutions and the trehalose anomaly. J Phys Chem 93:2880-2.
10. Hauser H, Strauss G. (1988). Stabilization of small, unilamellar phospholipid vesicles by sucrose during freezing and dehydration. Adv Exp Med Biol 238:71-80.
11. Kadimi US, Balasubramanian DR, Ganni UR, et al. (2007). In vitro studies on liposomal amphotericin B obtained by supercritical carbon dioxide-mediated process. Nanomedicine 3:273-80.
12. Koster KL. (1991). Glass formation and desiccation tolerance in seeds. Plant Physiol 96:302-4.
13. Koster KL, Lei YP, Anderson M, et al. (2000). Effects of vitrified and nonvitrified sugars on phosphatidylcholine fluid-to-gel phase transitions. Biophys J 78:1932-46.
14. Koster KL, Webb MS, Bryant G, Lynch DV. (1994). Interactions between soluble sugars and POPC (1-palmitoyl-2-oleoylphosphatidylcholine) during dehydration: vitrification of sugars alters the phase behavior of the phospholipid. Biochim Biophys Acta 1193: 143-50.
15. Koudelka S, Turanek-Knotigova P, Masek J, et al. (2010). Liposomes with high encapsulation capacity for paclitaxel: preparation, characterization and in vivo anticancer effect. J Pharm Sci 99:2309-19.
16. Lo YL, Tsai JC, Kuo JH. (2004). Liposomes and disaccharides as carriers in spray-dried powder formulations of superoxide dismutase. J Control Release 94:259-72.
17. Madden TD, Bally MB, Hope MJ, et al. (1985). Protection of large unilamellar vesicles by trehalose during dehydration: retention of vesicle contents. Biochim Biophys Acta 817:67-74.
18. Marupudi NI, Han JE, Li KW, et al. (2007). Paclitaxel: a review of adverse toxicities and novel delivery strategies. Expert Opin Drug Saf 6:609-21.
19. Mishima K. (2008). Biodegradable particle formation for drug and gene delivery using supercritical fluid and dense gas. Adv Drug Deliv Rev 60:411-32.
20. Ohtake S, Schebor C, De Pablo JJ. (2006). Effects of trehalose on the phase behavior of DPPC-cholesterol unilamellar vesicles. Biochim Biophys Acta 1758:65-73.
21. Sharma A, Mayhew E, Bolcsak L, et al. (1997). Activity of paclitaxel liposome formulations against human ovarian tumor xenografts. Int J Cancer 71:103-7.
22. Sharma A, Straubinger RM. (1994). Novel Taxol formulations: preparation and characterization of Taxol-containing liposomes. Pharm Res 11:889-96.
23. Strauss G, Schurtenberger P, Hauser H. (1986). The interaction of saccharides with lipid bilayer vesicles: stabilization during freezethawing and freeze-drying. Biochim Biophys Acta 858:169-80.
24. Sundaramurthi P, Patapoff TW, Suryanarayanan R. (2010). Crystallization of trehalose in frozen solutions and its phase behavior during drying. Pharm Res 27:2374-83.
25. Sundaramurthi P, Suryanarayanan R. (2010a). Influence of crystallizing and non-crystallizing cosolutes on trehalose crystallization during freeze-drying. Pharm Res 27:2384-93.
26. Sundaramurthi P, Suryanarayanan R. (2010b). Trehalose crystallization during freeze-drying: implications on lyoprotection. J Phys Chem Lett 1:510-14.
27. Sundaramurthi P, Suryanarayanan R. (2011). The effect of crystallizing and non-crystallizing cosolutes on succinate buffer crystallization and the consequent pH shift in frozen solutions. Pharm Res 28:374-85.
28. Torchilin V, Weissig V, eds. (2003). Liposomes: a practical approach. New York: Oxford University Press. Van Winden EC. (2003). Freeze-drying of liposomes: theory and practice. Methods Enzymol 367:99-110.
29. Varma MV, Panchagnula R. (2005). Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo. Eur J Pharm Sci 25:445-53.
30. Weiss RB, Donehower RC, Wiernik PH, et al. (1990). Hypersensitivity reactions from taxol. J Clin Oncol 8:1263-8.
31. Yang T, Cui FD, Choi MK, et al. (2007a). Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation. Int J Pharm 338:317-26.
32. Yang T, Cui FD, Choi MK, et al. (2007b). Liposome formulation of paclitaxel with enhanced solubility and stability. Drug Deliv 14: 301-8.
33. Zhang JA, Anyarambhatla G, Ma L, et al. (2005a). Development and characterization of a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU) formulation. Eur J Pharm Biopharm 59:177-87.
34. Zhang JQ, Zhang ZR, Yang H, et al. (2005b). Lyophilized paclitaxel magnetoliposomes as a potential drug delivery system for breast carcinoma via parenteral administration: in vitro and in vivo studies. Pharm Res 22:573-83.